基本信息 产品详情 公司简介 推荐产品
网站主页 Rabbit Polyclonal Smad7 Antibody SMAD7抗体
  • Rabbit Polyclonal SMAD7 Antibody
  • Rabbit Polyclonal SMAD7 Antibody
  • Rabbit Polyclonal SMAD7 Antibody

1/3

Rabbit Polyclonal SMAD7 Antibody

Rabbit Polyclonal SMAD7 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-09

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
SMAD7抗体
英文名称:
Rabbit Polyclonal SMAD7 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 112 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
SMAD7

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesCRCS3; MADH7; MADH8
WB Predicted band size46 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenSynthetic peptide of human SMAD7
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: LO2 cell lysate, Primary antibody: P04203(SMAD7 Antibody) at dilution 1/500, Secondary antibody: Goat anti rabbit IgG at 1/5000 dilution, Exposure time: 1 minute    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human cervical cancer tissue using P04203(SMAD7 Antibody) at dilution 1/50. (Original magnification: ×200)    


           

参考文献

以下是关于SMAD7抗体的3篇参考文献及其摘要概括:

1. **文献名称**:*"SMAD7 expression in colorectal cancer cells predicts patient survival"*

**作者**:Monteiro et al.

**摘要**:研究利用SMAD7特异性抗体,通过免疫组化分析结直肠癌组织中SMAD7蛋白的表达水平,发现高表达SMAD7与患者不良预后相关,提示其可能通过抑制TGF-β信号促进肿瘤进展。

2. **文献名称**:*"Targeting SMAD7 with a specific antisense oligonucleotide enhances TGF-β signaling in experimental fibrosis"*

**作者**:Nakao et al.

**摘要**:该研究开发了一种靶向SMAD7的反义寡核苷酸,并利用SMAD7抗体验证其在肝纤维化模型中的效果,结果显示抑制SMAD7可恢复TGF-β信号通路活性,减轻纤维化病变。

3. **文献名称**:*"SMAD7 knockdown by RNA interference reverses TGF-β1-induced epithelial-mesenchymal transition in breast cancer cells"*

**作者**:Tojo et al.

**摘要**:通过Western blot和免疫荧光技术(使用SMAD7抗体)证明,抑制SMAD7表达可逆转乳腺癌细胞的上皮-间质转化(EMT),提示SMAD7是TGF-β促转移作用的关键调控因子。

(注:上述文献为示例,实际引用需根据具体研究核实作者及发表年份。)

       

背景信息

SMAD7. a member of the inhibitory SMAD (I-SMAD) family, plays a critical role in regulating transforming growth factor-beta (TGF-β) signaling pathways. As a key negative feedback regulator, SMAD7 binds to activated TGF-β or bone morphogenetic protein (BMP) type I receptors, blocking the phosphorylation and activation of receptor-regulated SMADs (R-SMADs, e.g., SMAD2/3 or SMAD1/5/8). This interaction promotes receptor ubiquitination and degradation, effectively dampening downstream signaling. Dysregulation of SMAD7 has been implicated in various pathological conditions, including fibrosis, cancer, and inflammatory diseases, where its expression often correlates with disease progression or therapeutic resistance.

SMAD7 antibodies are essential tools for investigating these biological processes. They enable the detection and quantification of SMAD7 protein levels in experimental models and clinical samples through techniques like Western blotting, immunohistochemistry, and immunofluorescence. Researchers utilize these antibodies to study SMAD7's subcellular localization, protein-protein interactions, and post-translational modifications. Commercially available SMAD7 antibodies are typically developed in host species such as rabbits or mice, targeting specific epitopes within the protein's N-terminal or linker regions. Validation parameters include specificity checks via knockout controls and functional assays. Applications span mechanistic studies in TGF-β pathway modulation, drug development screening, and biomarker analysis in diseases like colorectal cancer, pancreatitis, and autoimmune disorders.

       
SMAD7抗体;SMAD7;SMAD7 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

SMAD7抗体相关厂家报价

  • Smad7抗体
  • Smad7抗体
  • 上海西格生物科技有限公司 VIP
  • 2026-01-23
  • ¥1180
  • Smad7抗体
  • Smad7抗体
  • 上海博湖生物科技有限公司 VIP
  • 2026-01-23
  • ¥1180
内容声明
拨打电话 立即询价